Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Prospective, Observational Study to Evaluate Therapeutic Effectiveness and Safety of Kabalin Cap. in Patients With Neuropathic Pain

NCT07930260 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07930260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Prospective, Observational Study to Evaluate Therapeutic Effectiveness and Safety of Kabalin Cap. in Patients With Neuropathic Pain
Lead sponsor
HK inno.N Corporation
Phase
Observational
Overall status
Recruiting
Start date
February 27, 2025
Completion date
June 30, 2028
Enrollment
5,217 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral or central neuropathic pain

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Proportion of participants with a ≥50% improvement in pain severity from baseline at Week 12 At Week 12 after enrollment

    The proportion of participants whose pain severity score, as assessed using the SF-MPQ, shows a ≥50% improvement from baseline after 12 weeks of treatment with Kabalin Cap. will be reported

Lead sponsor's other trials

HK inno.N Corporation, most recent start first.

Similar trials

Same condition (Neuralgia) and phase, most recent start first.